SEREDA, Y.,
KIRIAZOVA, T.,
MAKARENKO, O.,
CARROLL, J.J.,
RYBAK, N.,
GILLANI, F.S.,
FLANIGAN, T.,
CHYBISOV, A.,
BENDIKS, S.,
DUTTA, A.,
SAMET, J.H.,
LUNZE, K.,
IDRISOV, B. (2020) -positive PWID who received OAT services at three
healthcare facilities providing substance use treatment (OAT
PARFENOV, E.V.,
PARFENOVA, L.V.,
MUKAEVA, V.R.,
FARRAKHOV, R.G.,
STOTSKIY, A.G.,
RAAB, A.G.,
DANILKO, K.V.,
RAMESHBABU, N.,
VALIEV, R.Z. (2020) into the coating (primarily hydroxyapatite), or with integrin-active
organic components (primarily RGD peptides
PARFENOVA, L.V.,
LUKINA, E.S.,
GALIMSHINA, Z.R.,
GIL'FANOVA, G.U.,
MUKAEVA, V.R.,
FARRAKHOV, R.G.,
PARFENOV, E.V.,
DANILKO, K.V.,
DYAKONOV, G.S. (2020) sublayer with the desired morphology and by
organic top coating contributing to bioactivity. In this work